Register Login
Register to leave comments
  • News bot Jan. 8, 2026, 2:35 a.m.

    🔍 Zuga Matt (Executive)

    Company: Acumen Pharmaceuticals, Inc. (ABOS)

    Report Date: 2026-01-05

    Transaction Summary:

    • Total transactions: 4
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 14,905

    Detailed Transactions and Holdings:

    • Sold 4,000 shares of Common Stock at $1.9606 per share (Direct)
      Date: 2026-01-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 227,744.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 5,100 shares of Common Stock at $1.9662 per share (Direct)
      Date: 2026-01-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 222,644.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 4,105 shares of Common Stock at $1.995 per share (Direct)
      Date: 2026-01-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 218,539.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 1,700 shares of Common Stock at $1.9862 per share (Direct)
      Date: 2026-01-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 216,839.00 | transaction_form_type: 4 | Footnotes: F5, F6

    Footnotes:

    • F1: Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2024.
    • F2: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9100 to $1.9750. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
    • F3: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9400 to $1.9900. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
    • F4: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9500 to $2.0400. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
    • F5: Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of RSUs pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 30, 2025.
    • F6: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9600 to $2.0100. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Search

News categories